Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

BHCHX vs QAAGZX overlap: 50% of top holdings shared

Bottom line

How much do BHCHX and QAAGZX overlap?

50% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 44.8% of BHCHX's assets and 46.0% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.

QAAGZX holds far more positions (277 vs 43), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

BHCHXQAAGZX
Weight overlap (top 25)50%
Shared holdings13
Weight in shared holdings44.8%46.0%
Total positions43277
Expense ratio0.85%0.86%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings BHCHX and QAAGZX have in common

Holding% of BHCHX% of QAAGZXOverlap
Eli Lilly & Co13.66%14.06%13.66%
Johnson & Johnson5.56%6.64%5.56%
Thermo Fisher Scientific Inc3.91%2.53%2.53%
UnitedHealth Group Inc3.28%5.88%3.28%
Vertex Pharmaceuticals Inc2.61%2.26%2.26%
Merck & Co Inc2.48%4.00%2.48%
Guardant Health Inc2.17%1.22%1.22%
Kymera Therapeutics Inc2.01%0.89%0.89%
Gilead Sciences Inc1.99%2.79%1.99%
Natera Inc1.93%1.44%1.44%
Intuitive Surgical Inc1.74%1.89%1.74%
Protagonist Therapeutics Inc1.72%0.85%0.85%
Elevance Health Inc1.69%1.54%1.54%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in BHCHX

  1. Mettler-Toledo International Inc — 5.60%
  2. Argenx SE — 4.23%
  3. Roivant Sciences Ltd — 3.88%
  4. Teva Pharmaceutical Industries Ltd — 3.86%
  5. Welltower Inc — 3.38%
  6. RadNet Inc — 3.24%
  7. Billiontoone Inc — 2.84%
  8. Edwards Lifesciences Corp — 2.64%
  9. AstraZeneca PLC — 2.49%
  10. Madrigal Pharmaceuticals Inc — 2.12%
  11. Revolution Medicines Inc — 2.05%
  12. Elanco Animal Health Inc — 2.05%

Only in QAAGZX

  1. Abbvie Inc — 5.12%
  2. Bristol-myers Squibb Co — 2.12%
  3. Abbott Laboratories — 1.91%
  4. Amgen Inc — 1.80%
  5. Stryker Corp — 1.78%
  6. Danaher Corp — 1.44%
  7. Cardinal Health Inc — 1.04%
  8. Royalty Pharma Plc- Cl A — 0.97%
  9. Tenet Healthcare Corp — 0.94%
  10. Cvs Health Corp — 0.93%
  11. T. Rowe Price Government Reserve Fund — 0.87%
  12. Moderna Therapeutics Inc — 0.83%

Asset mix

Asset typeBHCHXQAAGZX
Stocks97.7%96.9%
Preferred stock—2.2%
Cash & short-term funds—0.9%
Bonds—0.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryBHCHXQAAGZX
US79.7%92.3%
NL4.5%1.0%
BM3.9%0.7%
IL3.9%0.2%
GB2.5%1.8%
CA1.9%0.6%
FR1.0%0.3%
IE—0.8%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do BHCHX and QAAGZX overlap?
About 50% by weight. 13 securities appear in both funds' top 25 holdings; they make up 44.8% of BHCHX's assets and 46.0% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do BHCHX and QAAGZX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, UnitedHealth Group Inc, Thermo Fisher Scientific Inc, Merck & Co Inc.
Should I own both BHCHX and QAAGZX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, BHCHX or QAAGZX?
QAAGZX is broader, with 277 positions versus 43 for BHCHX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.